Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), its partner for the Comirnaty COVID-19 vaccine, made legal submissions to ...

Moderna said Friday that the European Patent Office has upheld the validity of one of its key patents, a victory in a continuing dispute with Pfizer and BioNTech over rival COVID-19 vaccines.

Moderna Inc MRNA has reportedly achieved a significant victory at the European Patent Office (EPO) in its ongoing legal battle with Pfizer Inc PFE and BioNTech SE BNTX over the Covid-19 vaccine.

Pfizer Inc PFE, BioNTech SE BNTX, and Moderna Inc MRNA were named in lawsuits by Promosome accusing their COVID-19 vaccines of infringing a patent related to messenger RNA (mRNA) technology. The ...

Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that ...

Alnylam Pharmaceuticals has filed separate lawsuits alleging that Pfizer and Moderna infringed on its patents in developing their Covid-19 vaccines, the latest dispute over valuable intellectual ...

March 5 - MODERNA (MRNA, Financial) secured a major legal win in its COVID-19 vaccine patent dispute with Pfizer (PFE, Financial) and BioNTech (BNTX, Financial). A Dusseldorf court ruled in favor of ...

Three of the biggest COVID-19 vaccine developers are heading into a legal battle. Moderna Inc. said it has filed lawsuits alleging the Pfizer Inc.-Biontech SE Comirnaty vaccine infringes patents ...

For its part, Moderna said that, on Sept. 29, it offered to resolve the dispute by making the U.S. government co-owners of those patent applications that only listed Moderna scientists as inventors.

Moderna sues Pfizer and BioNTech over coronavirus vaccine patent Lawsuit sets up clash between rival vaccine makers who used novel mRNA technology to battle covid August 26, 2022 More than 2 years ago ...

Moderna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent Office (EPO) in its ongoing legal battle with Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX ...